Dr. Prithvi B. Murthy
Overview
Prithvi Murthy is an Urologist in Orland Park, Illinois. Dr. Murthy has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Enlarged Prostate (BPH), Cystectomy, and Vasectomy.
His clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Bladder Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
15234 S Harlem Ave, Orland Park, IL 60462
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The University Of Chicago
Piyush Agarwal is an Urologist in Chicago, Illinois. Dr. Agarwal is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy. Dr. Agarwal is currently accepting new patients.
Rci (Wrs), Llc.
Gary Steinberg is an Urologist in Crown Point, Indiana. Dr. Steinberg is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Ureteral Reconstruction. Dr. Steinberg is currently accepting new patients.
Loyola University Medical Center
Marcus Quek is an Urologist in Maywood, Illinois. Dr. Quek is rated as an Elite provider by MediFind in the treatment of Bladder Cancer. His top areas of expertise are Bladder Cancer, Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Cystectomy. Dr. Quek is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Murthy isDistinguished. Learn about Bladder Cancer.
- CystectomyDr. Murthy isDistinguished. Learn about Cystectomy.
- Advanced
- VasectomyDr. Murthy isAdvanced. Learn about Vasectomy.
- Experienced
- Bilateral HydronephrosisDr. Murthy isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder StonesDr. Murthy isExperienced. Learn about Bladder Stones.
- BoilsDr. Murthy isExperienced. Learn about Boils.
- CarbuncleDr. Murthy isExperienced. Learn about Carbuncle.
- ChoriocarcinomaDr. Murthy isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Murthy isExperienced. Learn about Chromophobe Renal Cell Carcinoma.